2-(Piperidin-1-yl)ethyl 4-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)benzoyl)piperazine-1-carbodithioate

ID: ALA4559783

PubChem CID: 155557866

Max Phase: Preclinical

Molecular Formula: C31H37ClN8O2S2

Molecular Weight: 653.28

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCCCC4)CC3)cc2)ncc1Cl

Standard InChI:  InChI=1S/C31H37ClN8O2S2/c1-33-28(41)24-7-3-4-8-26(24)36-27-25(32)21-34-30(37-27)35-23-11-9-22(10-12-23)29(42)39-15-17-40(18-16-39)31(43)44-20-19-38-13-5-2-6-14-38/h3-4,7-12,21H,2,5-6,13-20H2,1H3,(H,33,41)(H2,34,35,36,37)

Standard InChI Key:  DBZXJKBZMWSTGM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 44 48  0  0  0  0  0  0  0  0999 V2000
   36.7722  -27.5492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7710  -28.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4791  -28.7777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1888  -28.3683    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.1859  -27.5456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4773  -27.1404    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.8921  -27.1344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.6013  -27.5403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0644  -27.1408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3568  -27.5496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6491  -27.1394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9420  -27.5475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9417  -28.3655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6545  -28.7738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3587  -28.3634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6011  -28.3551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3095  -28.7610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0166  -28.3497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0109  -27.5283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3019  -27.1261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7264  -28.7547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7306  -29.5718    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.4320  -28.3425    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.1387  -28.7531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8422  -28.3444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8423  -27.5268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.1326  -27.1197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4229  -27.5301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6498  -26.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3579  -25.9143    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.9425  -25.9129    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9433  -25.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0630  -28.7768    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   44.5494  -27.1173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2577  -27.5250    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   44.5483  -26.3001    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   45.9648  -27.1155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.6731  -27.5231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.6742  -28.3403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   45.9659  -28.7438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.9650  -29.5575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.6715  -29.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.3804  -29.5606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.3830  -28.7408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  1  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  8  1  0
 18 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 11 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
  2 33  1  0
 26 34  1  0
 34 35  1  0
 34 36  2  0
 35 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 39 44  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4559783

    ---

Associated Targets(Human)

PTK2 Tclin Focal adhesion kinase 1 (4730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 653.28Molecular Weight (Monoisotopic): 652.2169AlogP: 5.24#Rotatable Bonds: 9
Polar Surface Area: 105.73Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.47CX Basic pKa: 8.64CX LogP: 6.43CX LogD: 5.16
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.27Np Likeness Score: -1.67

References

1. Su Y, Li R, Ning X, Lin Z, Zhao X, Zhou J, Liu J, Jin Y, Yin Y..  (2019)  Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities.,  177  [PMID:31129452] [10.1016/j.ejmech.2019.05.048]

Source